Links to publications that use this kit:
Bernard Beck, Sébastien Richy, Zoe A. Archer, Julian G. Mercer, Early and persistent up-regulation of hypothalamic orexigenic peptides in rat offspring born to dams fed a high-carbohydrate supplement during gestation.
Brain Res. 2012 Oct 5;1477:10-8. doi: 10.1016/j.brainres.2012.08.021. Epub 2012 Aug 17.
C. Nocjar, J. Zhang, P. Feng, J. Panksepp, The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus.
Neuroscience, Volume 218, 30 August 2012, Pages 138-153, ISSN 0306-4522, 10.1016/j.neuroscience.2012.05.033.
Rolf Fronczek, Sarita van Geest, Marijke Frölich, et al, Hypocretin (orexin) loss in Alzheimer's disease.
Neurobiol Aging. 2012 Aug;33(8):1642-50. doi: 10.1016/j.neurobiolaging.2011.03.014. Epub 2011 May 5.
Feng et al. The effect of clomipramine on wake/sleep and orexinergic expression in rats.
J Psychopharmacol. 2009 Jul;23(5):559-566.
Fogel et al. Satiety signalling histaminergic system and brain-gut peptides in regulation of food intake in rats with portocaval anastomosis.
J Physiol Pharmacol. 2008 Aug;59 Suppl 2:135-44.
Dickinson et al. Onset of feeding at birth--perinatal development of the hypothalamic mechanisms that induce appetite and feeding in the newborn.
Neurosci Lett. 2008 May 2;436(1):1-6.
Dauvilliers et al. Hypocretin and human African trypanosomiasis.
Sleep. 2008 Mar 1;31(3):348-54.
Munts et al. Analysis of cerebrospinal fluid inflammatory mediators in chronic complex regional pain syndrome related dystonia.
Clin J Pain. 2008 Jan;24(1):30-4.
Zeitzer et al. Increasing length of wakefulness and modulation of hypocretin-1 in the wake-consolidated squirrel monkey.
Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1736-42.
Feng et al. Brain orexins and wake regulation in rats exposed to maternal deprivation
Brain Res. 2007 Jun 18;1154:163-72.
Fronczek et al. Hypocretin (orexin) loss in Parkinson’s disease.
Brain. 2007 Jun;130(Pt 6):1577-85.
Paranjape et al. Role of dorsal vagal motor nucleus orexin-receptor-1 in glycemic responses to acute versus repeated insulin administration
Neuropeptides. 2007 Apr;41(2):111-6
Jeong et al. HLA-DQB1 Allele and Hypocretin in Korean Narcoleptics with Cataplexy
J Korean Med Sci. 2007 Feb;22(1):127-31.
Dohi et al. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
Peptides. 2005 Nov;26(11):2339-43.
Petersen et al. Orexin loss in Huntington's disease.
Hum Mol Genet. 2005 Jan 1;14(1):39-47.
Kappeler et al. Plasma and Hypothalamic Peptide-Hormone Levels Regulating Somatotroph Function and Energy Balance in Fed and Fasted States: A Comparative Study in Four Strains of Rats
J Neuroendocrinol. 2004 Dec;16(12):980-8.
Deboer et al. Convergence of circadian and sleep regulatory mechanisms on hypocretin-1
Neuroscience. 2004;129(3):727-32.
Baumann et al. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
Eur Neurol. 2004;52(2):73-6.
Gerashchenko et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss
Exp Neurol. 2003 Dec;184(2):1010-6.
Zeitzer et al. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness.
J Neurosci. 2003 Apr 15;23(8):3555-60.
Ebrahim et al. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):127-30.
Kiyashchenko et al. Release of Hypocretin (Orexin) during Waking and Sleep States
J Neurosci. 2002 Jul 1;22(13):5282-6.
Yoshida et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities
Eur J Neurosci. 2001 Oct;14(7):1075-81.
Nishino et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.
Ann Neurol. 2001 Sep;50(3):381-8.
Ripley et al. Hypocretin Levels in Sporadic and Familial Cases of Canine Narcolepsy
Neurobiol Dis. 2001 Jun;8(3):525-34.
Fujiki et al. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation
Neuroreport. 2001 Apr 17;12(5):993-7.
Peyron et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
Nat Med. 2000 Sep;6(9):991-7.
in CSF: Nishino et al. - Annuals of Neurology - Vol. 50 - No. 3 - Sep. 2001 - pg 381 and for Hypocretin: Arii J. - Neurology - 56 - (2001) / in CSF: Snow A. - PEDIATRICS Vol. 110 No. 6 December 2002 - pp. e74